Welcome to LookChem.com Sign In|Join Free
  • or
(1RS,2RS)-2-amino-1-(4-fluorophenyl)propan-1-ol is an organic compound belonging to the class of alcohols, characterized by its molecular formula C9H12FNO and a molecular weight of 167.2 g/mol. As a chiral molecule, it exists in two enantiomeric forms, which contribute to its unique properties and applications. The presence of the 4-fluorophenyl group endows the compound with distinctive features, making it a versatile building block in organic chemistry and drug development.

109515-15-3

Post Buying Request

109515-15-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

109515-15-3 Usage

Uses

Used in Pharmaceutical Synthesis:
(1RS,2RS)-2-amino-1-(4-fluorophenyl)propan-1-ol is utilized as an intermediate in the synthesis of pharmaceuticals, leveraging its unique structure and properties to facilitate the development of new drugs and medicinal compounds.
Used in Organic Chemistry:
In the field of organic chemistry, (1RS,2RS)-2-amino-1-(4-fluorophenyl)propan-1-ol serves as an important building block, enabling chemists to explore a variety of chemical reactions and applications, further expanding the scope of organic synthesis and compound design.

Check Digit Verification of cas no

The CAS Registry Mumber 109515-15-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,5,1 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 109515-15:
(8*1)+(7*0)+(6*9)+(5*5)+(4*1)+(3*5)+(2*1)+(1*5)=113
113 % 10 = 3
So 109515-15-3 is a valid CAS Registry Number.

109515-15-3Downstream Products

109515-15-3Relevant academic research and scientific papers

Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) Inhibitors

Fujimoto, Jun,Okamoto, Rei,Noguchi, Naoyoshi,Hara, Ryoma,Masada, Shinichi,Kawamoto, Tetsuji,Nagase, Hiroki,Tamura, Yumiko Okano,Imanishi, Mitsuaki,Takagahara, Shuichi,Kubo, Kazuki,Tohyama, Kimio,Iida, Koichi,Andou, Tomohiro,Miyahisa, Ikuo,Matsui, Junji,Hayashi, Ryouta,Maekawa, Tsuyoshi,Matsunaga, Nobuyuki

, p. 8963 - 8981 (2017)

The discovery and optimization of Δ-5 desaturase (D5D) inhibitors are described. Investigation of the 1,3-oxazolidin-2-one scaffold was inspired by a pharmacophore model constructed from the common features of several hit compounds, resulting in the identification of 3,5-diphenyl-1,3-oxazolidin-2-one 5h as a novel lead showing potent in vitro activity. Subsequent optimization focused on the modification of two metabolic sites, which provided (4S,5S)-5i, a derivative with improved metabolic stability. Moreover, adding a substituent into the upper phenyl moiety further enhanced the intrinsic activity, which led to the discovery of 5-[(4S,5S)-5-(4fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzene-1,3-dicarbonitrile (4S,5S)-5n, endowed with excellent D5D binding affinity, cellular activity, and high oral bioavailability in a mouse. It exhibited robust in vivo hepatic arachidonic acid/dihomo-γ-linolenic acid ratio reduction (a target engagement marker) in an atherosclerosis mouse model. Finally, an asymmetric synthetic procedure for this compound was established.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 109515-15-3